Board of Directors
The Company
Company Overview
Mission Statement
Management Team
Directors
Scientific Advisory Board
Business Strategy Advisory Board
 

Board of Directors

Zami Aberman, Co-Chairman, Pluristem's President & CEO
Aberman joined Pluristem in September 2005 and changed the Company’s strategy towards cellular therapeutics. Mr. Aberman has 20 years of experience in marketing and management in the high technology industry. He has held Chief Executive and Chairman positions in Israel, the USA, Europe, Japan and Korea. He has operated within high-tech global companies in the fields of automatic optical inspection, network security, video over IP, software, chip design and robotics. Mr. Aberman serves as the Chairman of Rose Hitech Ltd., a private investment company; and has served in the past as the Chairman of VLScom Ltd., a private company specializing in video compression for HDTV and video over IP and as a Director of Ori Software Ltd., a company involved in data management. Prior to that, he served as the President and CEO of Elbit Vision Systems (EVSNF.OB), which supplies inspection systems for the microelectronic industry.

Mr. Aberman has served as President and CEO of Netect Ltd., specializing in the field of internet security software and was the Co-Founder, President and CEO of Associative Computing Ltd., which developed an associative parallel processor for real-time video processing. He has also served as Chairman of Display Inspection Systems Inc., specializing in laser based inspection machines and as President and CEO of Robomatix Technologies Ltd. (RBMXF.OB).

In 1992, Aberman was awarded the Rothschild Prize for excellence in his field from the President of the State of Israel. Aberman holds a B.Sc. in Mechanical Engineering from Ben Gurion University in Israel.

top


Mark Germain, Co-Chairman
Mr. Germain was appointed Co-Chairman of the Board of Directors on May 17, 2007. For more than the past five years, Mr. Germain has been a merchant banker serving primarily the biotech and life sciences industries. He has been involved as a founder, director, Chairman of the Board of, and/or investor in over twenty companies in the biotech field, and assisted many of them in arranging corporate partnerships, acquiring technology, entering into mergers and acquisitions, and executing financings and going public transactions. He graduated New York University School of Law in 1975, Order of the Coif, and was a partner in a New York law firm practicing corporate and securities law before leaving for the private sector in 1986. Since then, and until he entered the biotech field in 1991, he served in senior executive capacities, including as president of a public company sold in 1991. In addition to being Co-Chairman of the Company, Mr. Germain is a director of the following publicly traded companies: Wellford Real Properties, Inc., Stem Cell Innovations, Inc., and Collexis Holdings, Inc. He is also a co-founder and director of a number of private companies in the biotechnology field.

top


 

Mr. Doron Shorrer
Doron Shorrer (CPA, Israel) was Chairman of the Board of Phoenix Insurance Company, one of the largest insurance companies in Israel and Mivtachim Pension Benefit Group, the largest pension fund in Israel, managing $15 billion. Before assuming these positions, Shorrer held senior appointments that included: Arbitrator at the Claims Resolution Tribunal for Dormant Accounts in Switzerland; Economic and Financial Advisor, Commissioner of Insurance and Capital Markets for the State of Israel; Member of the Board of Directors of "Nechasim" of the State of Israel; Member of the Committee for the Examination of Structural Changes in the Capital Market (The Brodet Committee); General Director of the Ministry of Transport; Co-Founder and Director of an accounting firm having three branches (Jerusalem, Tel-Aviv, Haifa); Member of the Lecture Staff of the Amal School Chain; Chairman of a Public Committee for Telecommunications; and Economic Consultant to the Ministry of Energy.

Among many areas of expertise, Mr. Shorrer formulates, implements and administers business planning in the private and institutional sector. Additionally, Mr. Shorrer consults on economic, accounting and taxation issues to a large audience, ranging from private concerns to government ministries. Mr. Shorrer holds a B.A. in Economics and Accounting and an M.A. in Business Administration (specialization in finance and banking) from the Hebrew University of Jerusalem. He is a Certified Public Accountant (ISR).

top




Ms. Hava Klemperer Meretzki
Hava Klemperer Meretzki, Adv. is a partner in the law firm of Ben-Noun Meretzki in Haifa, Israel. She specializes in civil, trade and labor law and is presently Vice-Chairman for the National Council of the Israel Bar Association. She previously was a Director of the Israel Electric Company. Ms. Meretzki received a Bachelors Degree in Law from the Hebrew University in 1991, and, in 1992, was admitted to the Israel Bar Association.

top


 


Isaac Braun
Mr. Braun was appointed a director of Pluristem on July 6, 2005. Mr. Braun is a business veteran with entrepreneurial, industrial and manufacturing experience. He has been a co-founder and board member of several hi-tech start-ups in the areas of e-commerce, security, messaging, search engines and biotechnology. Mr. Braun advises private companies on raising financing and business development.

top



Israel Ben Yoram
Mr. Ben-Yoram was appointed a director of Pluristem on January 26, 2005. Mr. Ben-Yoram has been a director and partner in the accounting firm of Mor, Ben-Yoram and Partners in Israel from 1985 to the present. This accounting firm currently employs over 15 employees in the field of auditing, consulting, and associated projects. Since 1992, Mr. Ben-Yoram has served as a shareholder and the head director of Mor, Ben-Yoram Ltd., a private company in Israel, in parallel with the operation of the Mor, Ben-Yoram and Partners accounting firm. This company provides management services, economic consulting services and other professional services to businesses. Mr. Ben-Yoram received a B.A. in accounting from the University of Tel Aviv, an M.A. in Economics from the Hebrew University of Jerusalem, an LLB and an MBA from Tel Aviv University and an LLM from Bar-Ilan University.

top



Nachum Rosman
Mr. Rosman is an expert in finance, management and organization. He has held Chief Executive and CFO positions in Israel, USA and England. He has operated in High-Tech global companies in Software and Business. In these jobs he was responsible for finance management, fund-raising, acquisitions, technology sales, preparation of financial reports for due diligences, etc.
Mr. Rosman serves as a consultant to start up companies in financing, strategy and reorganization. He serves as the CEO of Multiview Ltd, a company he co-founded in 1999. He serves as a director at Zoomix data mastering and Knolan.
Mr. Rosman was a director actively involved in the sale of New Dimension Ltd. to B.M.C. Inc. for $675 million. Prior to that he held a Co-CEO position in R.T.S. Ltd. (Virinet Ltd.), where he participated in the IPO in NASDAQ.

top


Shai Pines
Mr. Pines is a lawyer admitted to practice law in the State of Israel since 1981. He is a partner with, and heads the Commercial and International Transactions Department of, the Israeli law firm of Hamburger Evron & Co. Since 2000 Mr. Pines served as a member of the Supervisory Board of Globe Trade Centre SA (GTC), a Polish company, which is traded on the Warsaw Stock Exchange, and between the years 2000 - 2005 as a member of the Supervisory Board of GTC International BV, a Dutch private company. Mr. Pines is also a member of the Board of Governors of the Law Faculty of the Tel-Aviv University since 2006. Mr. Pines holds an MBA degree from Kellogg School of Management, Northwestern University, U.S.A. & the Leon Recanati Graduate School of Business Administration, Tel-Aviv University and an LL.B. degree from Tel-Aviv University.

top

Home   |   The Company   |   Technology   |   Investor Relations   |   Press Room   |   Privacy policy   |   Contact Us
Copyright © 2008 Pluristem Therapeutics Inc. All rights reserved Design by Mootag